US Patent Issued to Celgene on Aug. 26 for "Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use" (California, New Jersey Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,396,995, issued on Aug. 26, was assigned to Celgene Corp. (Summit, N.J.).

"Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use" was invented by Maria Soraya Carrancio Anton (San Diego), Tonia J. Buchholz (Moss Beach, Calif.), Henry Chang (San Francisco), Ellen Filvaroff (San Francisco), Shailaja Kasibhatla (San Diego), Antonia Lopez-Girona (San Diego), Adithi Mohan (San Mateo, Calif.), Rama Krishna Narla (San Diego), Michael Pourdehnad (San Francisco), William Edward Pierceall (Madison, N.J.) and Anjan Guha Thakurta (Basking Ridge, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of...